Search by Drug Name or NDC
NDC 50090-2925-00 Polymyxin B Sulfate and Trimethoprim 10000; 1 [USP'U]/mL; mg/mL Details
Polymyxin B Sulfate and Trimethoprim 10000; 1 [USP'U]/mL; mg/mL
Polymyxin B Sulfate and Trimethoprim is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE.
MedlinePlus Drug Summary
Polymyxin B and trimethoprim ophthalmic combination is used to treat bacterial infections of the eye including conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeball and the inside of the eyelid) or blepharoconjunctivitis (infection of the membrane that covers the outside of the eyeball and the inside and outer parts of the eyelid). Polymyxin B and trimethoprim are in a class of medications called antibiotics. They work by killing bacteria that cause infections.
Related Packages: 50090-2925-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Polymyxin B and Trimethoprim Ophthalmic
Product Information
| NDC | 50090-2925 |
|---|---|
| Product ID | 50090-2925_024ad216-7433-4c9d-938b-1a8a63316f26 |
| Associated GPIs | 86109902602020 |
| GCN Sequence Number | 048570 |
| GCN Sequence Number Description | polymyxin B sulf/trimethoprim DROPS 10000-1/ML OPHTHALMIC |
| HIC3 | Q6W |
| HIC3 Description | OPHTHALMIC ANTIBIOTICS |
| GCN | 14294 |
| HICL Sequence Number | 004710 |
| HICL Sequence Number Description | POLYMYXIN B SULFATE/TRIMETHOPRIM |
| Brand/Generic | Generic |
| Proprietary Name | Polymyxin B Sulfate and Trimethoprim |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Polymyxin B Sulfate and Trimethoprim |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 10000; 1 |
| Active Ingredient Units | [USP'U]/mL; mg/mL |
| Substance Name | POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA064211 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-2925-00 (50090292500)
| NDC Package Code | 50090-2925-0 |
|---|---|
| Billing NDC | 50090292500 |
| Package | 10 mL in 1 BOTTLE, PLASTIC (50090-2925-0) |
| Marketing Start Date | 2017-03-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |